Debbie L Hay Selected Research

Debbie L Hay Research Topics

Disease

33	Migraine Disorders (Migraine) 02/2022 - 01/2005
6	Headache (Headaches) 02/2022 - 01/2021
6	Obesity 01/2022 - 09/2010
4	Pain (Aches) 01/2022 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 10/2011
2	Facial Pain (Myofacial Pain) 01/2022 - 06/2015
2	Migraine without Aura (Common Migraine) 01/2021 - 01/2021
2	Type 2 Diabetes Mellitus (MODY) 07/2015 - 11/2014
2	Insulin Resistance 09/2010 - 01/2008
1	Hypersensitivity (Allergy) 01/2021
1	Photophobia (Light Sensitivity) 10/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2020
1	Chronic Disease (Chronic Diseases) 01/2018
1	Headache Disorders (Headache Syndromes) 05/2017
1	Diabetes Mellitus 06/2016
1	Metabolic Diseases (Metabolic Disease) 01/2016
1	Weight Loss (Weight Reduction) 07/2015
1	Neurogenic Inflammation 12/2013
1	Decompression Sickness (Bends) 12/2013
1	Osteoporosis 09/2012
1	Neoplasms (Cancer) 02/2011
1	Body Weight (Weight, Body) 09/2010
1	Septic Shock (Toxic Shock Syndrome) 12/2009
1	Flushing 10/2009
1	Sepsis (Septicemia) 04/2003

Drug/Important Bio-Agent (IBA)

21	Calcitonin Gene-Related PeptideIBA 01/2022 - 12/2006
14	Peptides (Polypeptides)IBA 02/2022 - 04/2003
10	Islet Amyloid PolypeptideIBA 01/2022 - 11/2014
10	NeuropeptidesIBA 01/2022 - 09/2010
8	Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA 01/2022 - 02/2011
7	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2022 - 12/2006
6	AdrenomedullinIBA 01/2022 - 04/2003
5	Pharmaceutical PreparationsIBA 02/2022 - 09/2012
4	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 01/2022 - 01/2016
4	pramlintide (Symlin)FDA Link 01/2021 - 11/2014
4	olcegepantIBA 01/2018 - 01/2005
3	Hormones (Hormone)IBA 06/2016 - 11/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 12/2021
2	Calcitonin Receptors (Calcitonin Receptor)IBA 01/2022 - 04/2017
2	Islet Amyloid Polypeptide ReceptorsIBA 01/2021 - 04/2017
2	Amylin Receptor AgonistsIBA 09/2018 - 07/2015
2	telcagepantIBA 01/2018 - 12/2009
2	Insulin (Novolin)FDA Link 06/2016 - 11/2014
2	Amino Acids FDA Link 01/2016 - 12/2013
2	Secretin FDA Link 09/2012 - 10/2011
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2012 - 10/2011
2	LipidsIBA 09/2010 - 01/2008
1	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 02/2022
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 02/2022
1	atogepantIBA 01/2022
1	LigandsIBA 12/2021
1	AntibodiesIBA 12/2021
1	Vasodilator Agents (Vasodilators)IBA 01/2021
1	Fluorescent Dyes (Fluorescent Probes)IBA 04/2020
1	rimegepant sulfateIBA 01/2020
1	Peptide Receptors (Peptide Receptor)IBA 09/2018
1	Glucagon-Like Peptide 1 (GLP 1)IBA 09/2018
1	calcitonin gene-related peptide (8-37)IBA 01/2018
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 06/2016
1	Calcitonin Receptor-Like ProteinIBA 01/2012
1	Glucose (Dextrose)FDA LinkGeneric 09/2010

Therapy/Procedure

10	Therapeutics 02/2022 - 02/2011
1	Precision Medicine 01/2021